Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             20 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Chronic obstructive pulmonary disease: new therapies and old needs Hopkinson, Nicholas S

13 3 p. 193-194
artikel
2 Correction to Lancet Respir Med 2025; 13: 244–55
13 3 p. e19
artikel
3 Correction to Lancet Respir Med 2025; 13: 256–71
13 3 p. e19
artikel
4 Corticosteroids in community-acquired pneumonia: a step forward, but questions remain Reyes, Luis Felipe

13 3 p. 191-193
artikel
5 Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials Bhatt, Surya P

13 3 p. 234-243
artikel
6 Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial Castro, Mario

13 3 p. 208-220
artikel
7 Home-based monitoring in chronic respiratory diseases: in search of Panacea Roche, Nicolas

13 3 p. e17-e18
artikel
8 How Glasgow's 1957 tuberculosis screening programme could help countries today Ranscombe, Peter

13 3 p. 203-204
artikel
9 Idiopathic inflammatory myopathies related lung disease in adults Sehgal, Sameep

13 3 p. 272-288
artikel
10 Management and mechanisms of eosinophil action in asthma: mind the gap? Russell, Richard E K

13 3 p. 190-191
artikel
11 On the front lines of the sepsis crisis: hurdles faced by sepsis researchers, survivors, and family advocates Duda, Jackie

13 3 p. 205-206
artikel
12 Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials Smit, Jim M

13 3 p. 221-233
artikel
13 Social and environmental determinants of health inequities in childhood asthma Alsulami, Saleh

13 3 p. 197-199
artikel
14 Spirometry—one size doesn't fit all The Lancet Respiratory Medicine,

13 3 p. 189
artikel
15 Stubble: the Farmer's Bane Burki, Talha

13 3 p. 207
artikel
16 Vaccine policy experts concerned about second Trump Administration Furlow, Bryant

13 3 p. 200-201
artikel
17 Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial Hoppe, Jordana E

13 3 p. 244-255
artikel
18 Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials Keating, Claire

13 3 p. 256-271
artikel
19 What does the expanding CFTR modulator programme mean for people with cystic fibrosis? Southern, Kevin W

13 3 p. 195-197
artikel
20 Wildfires in southern California: concerns for lung health Burki, Talha

13 3 p. 202
artikel
                             20 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland